|
Originally published In Press as doi:10.1074/jbc.M007049200 on September 26, 2000
J. Biol. Chem., Vol. 275, Issue 50, 39625-39630, December 15, 2000
Age-related Macular Degeneration
THE LIPOFUSCIN COMPONENT
N-RETINYL-N-RETINYLIDENE ETHANOLAMINE DETACHES
PROAPOPTOTIC PROTEINS FROM MITOCHONDRIA AND INDUCES APOPTOSIS IN
MAMMALIAN RETINAL PIGMENT EPITHELIAL CELLS*
Marianne
Suter ,
Charlotte
Remé§,
Christian
Grimm§,
Andreas
Wenzel§,
Marja
Jäättela¶,
Peter
Esser ,
Norbert
Kociok ,
Marcel
Leist**, and
Christoph
Richter 
From the Institute of Biochemistry, Swiss Federal
Institute of Technology, Universitätstr. 16, CH-8092 Zurich,
Switzerland, § Laboratory for Retinal Cell Biology,
Department of Ophthalmology, University Hospital Zurich,
Frauenklinikstr. 24, CH-8091 Zurich, Switzerland, ¶ Danish Cancer
Society, Apoptosis Laboratory, Strandboulevarden 49, DK-2100
Copenhagen, Denmark, Eye Clinic, University of Cologne, Joseph
Stelzmannstr. 9, D-50931 Cologne, Germany, and ** Department of
Molecular Toxicology, Faculty of Biology, University of Constance,
D-78457 Constance, Germany
Received for publication, August 4, 2000, and in revised form, September 13, 2000
 |
ABSTRACT |
10-20% of individuals over the age of 65 suffer from age-related macular degeneration (AMD), the leading cause
of severe visual impairment in humans living in developed countries.
The pathogenesis of this complex disease is poorly understood, and no
efficient therapy or prevention exists to date. A precondition for AMD
appears to be the accumulation of the age pigment lipofuscin in
lysosomes of retinal pigment epithelial (RPE) cells. In AMD, these
cells seem to die by apoptosis with subsequent death of photoreceptor cells, and light may accelerate the disease process. Intracellular factors leading to cell death are not known. Here we show that the
lipophilic cation N-retinyl-N-retinylidene
ethanolamine (A2E), a lipofuscin component, induces apoptosis in RPE
and other cells at concentrations found in human retina. Apoptosis is
accompanied by the appearance of the proapoptotic proteins cytochrome
c and apoptosis-inducing factor in the cytoplasm and the
nucleus. Biochemical examinations show that A2E specifically targets
cytochrome oxidase (COX). With both isolated mitochondria and purified
COX, A2E inhibits oxygen consumption synergistically with light.
Inhibition is reversed by the addition of cytochrome c or
cardiolipin, a negatively charged phospholipid that facilitates the
binding of cytochrome c to membranes. Succinate
dehydrogenase activity is not altered by A2E. We suggest that A2E can
act as a proapoptotic molecule via a mitochondria-related mechanism,
possibly through site-specific targeting of this cation to COX. Loss of
RPE cell viability through inhibition of mitochondrial function might
constitute a pivotal step toward the progressive degeneration of the
central retina.
 |
INTRODUCTION |
Age-related macular degeneration
(AMD)1 affects 10-20% of
people at an age over 65 and constitutes one of the leading causes of
severe visual impairment in the elderly in industrialized nations (1).
Whereas the clinical and the histopathological pictures of AMD are well
known (2, 3), molecular events initiating the disease remain elusive.
Major obstacles in elucidating such events are the lack of suitable
animal models and the complexity of the human disease. Recent studies
indicate that genetic components (4-8) and exogenous enhancing factors
(9, 10) both contribute to the pathogenesis.
In the course of photoreceptor renewal, rod outer segment tips are shed
and phagocytosed by the underlying cells of the retinal pigment
epithelium (RPE) (11-13). It is generally believed that the
accumulation of the autofluorescent age pigment lipofuscin in RPE cell
phagolysosomes constitutes a predicament for the development of the
disease. Lipofuscin accumulation and the formation of drusen and other
deposits in the region of Bruch's membrane, which separates the
pigment epithelium from the underlying choroid are considered initial
steps in the pathogenesis of AMD. Drusen formation may be the result of
progressive death and/or exocytosis of RPE cells in the central retina
(14, 15).
Lipofuscin harbors two unusual retinoids, the lipophilic cations
N-retinyl-N-retinylidene ethanolamine (A2E) and
its isoform, iso-A2E, first isolated from the eyes of old
individuals (16, 17). The molecules can be synthesized from two
retinals and one ethanolamine (17), both components of photoreceptor
outer segment membranes, where 11-cis-retinal serves as the
chromophore of the visual pigment rhodopsin and
phosphatidylethanolamine is an abundant membrane phospholipid.
During AMD, RPE cells may be lost by apoptosis as evidenced with human
autopsy eyes (18). Apoptosis is a form of cell death that, in addition
to its physiological importance in tissue development and homeostasis
(19), plays a major role in diseases such as cancer, acquired immune
deficiency syndrome, autoimmune diseases, and tissue degeneration (for
a review, see Ref. 20). Mitochondria are important control centers of
apoptosis (21, 22). When they are destabilized, for example by
oxidative stress, they release apoptosis-inducing proteins. One is
cytochrome c, which in the cytoplasm often but not always
(23) activates caspases, apoptosis-specific proteases. Another protein
is apoptosis-inducing factor (AIF), which induces nuclear apoptosis
independently of caspase activation (24, 25). Present knowledge
suggests that mitochondria function as cellular sensors of stress into
which different apoptosis induction pathways converge and that
mitochondria act as central executioners of apoptosis (26).
We show here that A2E induces apoptosis in cultures of various
mammalian cell types, including RPE cells. A2E-induced apoptosis is
preceded by a decline in mitochondrial activity and is accompanied by
translocation of cytochrome c and AIF into the cytoplasm and nucleus. Biochemical experiments suggest that A2E targets directly the
function of COX, whereas respiratory chain activity upstream of
cytochrome c is not affected by A2E. We propose that A2E can induce apoptosis by mobilizing cytochrome c and AIF from
mitochondria. Our findings give insight into the molecular mechanism
underlying A2E's cytotoxicity and suggest strategies to retard or
overcome AMD.
 |
EXPERIMENTAL PROCEDURES |
Animals--
8-Day-old specific pathogen free BALB/c mice were
obtained from the Animal Unit of the University of Constance, and
female Wistar rats were from the Animal Unit of the Institute of
Biochemistry (Swiss Federal Institute of Technology, Zurich). All
experiments were performed in accordance with international guidelines
to minimize pain and discomfort (National Institutes of Health
guidelines and European Community Council Directive 86/609/EEC) and
conformed to the ARVO statement for care and use of animals in research.
Cell Culture--
RPE cells were prepared from porcine eyes
obtained from a local slaughterhouse essentially as described
previously (27). The purity of the culture was verified by
immunohistochemical staining with anti-cytokeratin antibodies (Sigma
c-2931). Experiments were performed with passage 1-2 RPE cells that
were maintained in Dulbecco's modified Eagle's medium containing 10%
fetal calf serum, 50 µg/ml gentamycin, and 2.5 µg/ml amphotericin.
Murine cerebellar granule cells (CGC) were isolated from 8-day-old
BALB/c mice and cultured as described (28). Contamination with
nonneuronal cells ( -III-tubulin-negative) was <5%. Dissociated neurons were plated on 100 µg/ml (250 µg/ml for glass surfaces) poly-L-lysine ( > 300 kDa)-coated dishes at a
density of about 0.25 × 106 cells/cm2
(800,000 cells/ml; 500 µl/well, 24-well plate) and cultured in Eagle's basal medium (Life Technologies, Inc.) supplemented with 10%
heat-inactivated fetal calf serum, 20 mM KCl, 2 mM L-glutamine plus penicillin/streptomycin,
and cytosine arabinoside (10 µM; added 48 h after
plating). CGC were used without further medium changes after 5 days in
culture. The cells were exposed to A2E in their original medium in the
presence of 2 µM
(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK801; Biotrend Chemikalien GmbH) and 2 mM
Mg2+ to prevent
N-methyl-D-aspartate receptor activation
and excitotoxicity (29, 30).
Viability Assays--
Apoptosis and secondary lysis were
routinely quantified by double staining of neuronal cultures with 1 µg/ml H-33342 (membrane-permeant, blue fluorescent chromatin stain;
Molecular Probes, Inc., Eugene, OR) and 0.5 µM SYTOX
(non-membrane-permeant, green fluorescent chromatin stain; Molecular
Probes) as described previously (31, 32). Apoptotic cells were
characterized by scoring typically condensed nuclei. About 200-300
cells were counted in two or three different culture wells, and
experiments were repeated with at least three different preparations.
In addition, mitochondrial activity was quantified by the
reduction of 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrasodium bromide (MTT) (incubation for 60 min with 0.5 mg MTT/ml).
Immunocytochemistry--
CGC were grown on glass-bottomed
culture dishes, fixed after the experiment with 4% paraformadehyde,
and permeabilized with 0.1% Triton X-100 (for cytochrome c)
or 0.1% SDS (for AIF). Staining of cytochrome c
(anti-cytochrome c antibody; clone 6H2.B4, Pharmingen, Hamburg, Germany) was performed as described (33, 34). Rabbit anti-AIF
serum (24) was used at a dilution of 1:500. AlexaTM-568
coupled anti-mouse IgG antibody (1:300; Molecular Probes) served
as secondary antibody. CGC were embedded in phosphate-buffered saline containing 50% glycerol and 0.5 µg/ml H-33342 and imaged by
confocal microscopy (TCS-4D UV/VIS confocal scanning system; Leica AG,
Benzheim, and Leica Lasertechnik, Heidelberg, Germany). A2E shows a
strong green and red fluorescence when excited at 488 or 568 nm. The
red fluorescence is very photolabile and can be eliminated by short
illumination with a 50-watt lamp. Thereafter A2E fluorescence in the
green channel was easily distinguished from the fluorescence of
red-emitting fluorophores used for co-staining.
Mitochondrial Membrane Potential--
Mitochondrial membrane
potential in CGC was monitored as described (23, 29) after loading
cells with 5 nM tetramethylrhodamine ethylester (TMRE;
Molecular Probes) on a coverslip-bottomed cell culture dish. The images
were obtained with a confocal microscope (Leica TCS-4D; Leica,
Heidelberg, Germany) and a × 63, NA 1.32 lens. For dissipation of
the membrane potential, carbonylcyanide-3-chlorophenylhydrazone was
added to the cultures. The decay of TMRE fluorescence (excitation, 568 nm; emission, > 586 nm) and of A2E fluorescence (excitation, 488 nm;
emission, >515 nm) was monitored individually in control experiments
or simultaneously with A2E fluorescence (A2E emission filter set to
520 ± 10 nm).
Synthesis, Purification, and HPLC Analysis of A2E and
iso-A2E--
A2E and iso-A2E were synthesized from
all-trans-retinal and ethanolamine as described (17) and
purified chromatographically on silica gel 60 thin layer chromatography
plates using the primary developing system (35). A2E and
iso-A2E, the former being the faster moving band, were
detected on the plates by their fluorescence upon illumination with
366-nm light. The material containing A2E and iso-A2E was
scraped off, eluted with chloroform/methanol/water (30/25/4), dried,
and rechromatographed. Stock solutions of A2E and iso-A2E
were stored in Me2SO at 20 °C in the dark.
Total A2E diluted into methanol was quantified using a molar extinction coefficient of 36,900 at 439 nm (17). For HPLC, total A2E was loaded
onto a reversed phase column (Nucleosil 100-5 C18; 150 × 4.6 mm;
Macherey-Nagel, Oensingen, Switzerland) and eluted with a gradient of
methanol (plus 0.1% trifluoroacetic acid) in water (86-100% in 20 min). A2E and iso-A2E were detected at 436 nm with a peak
maximum at 16 and 19 min, respectively.
Photoisomerization of A2E and iso-A2E--
Photoisomerization
was induced by illuminating purified A2E or iso-A2E with
white light (70 watts, at 14-cm distance). The extent of isomerization
was analyzed by HPLC analysis (see above). The isomers reached
equilibrium in about 10 min.
Cytotoxicity of A2E and Apoptosis Assays--
A2E was diluted
into the RPE cell culture medium to a concentration of 25 µM A2E and 0.5% Me2SO. Control incubations
were done with 0.5% Me2SO in the absence of A2E as
negative control and with 0.5 µM staurosporine as
positive control. Incubation was at 37 °C with 5% CO2
for 24 h in darkness. For TUNEL staining (TUNEL assay; Roche
Molecular Biochemicals), formaldehyde-fixed cells were equilibrated in
30 mM Tris, 140 mM sodium cacodylate, pH 7.2, treated with terminal transferase (0.25 units/µl) and biotin-dUTP (20 µM) in the above buffer containing 1 mM
cobalt chloride for 60-90 min at 37 °C, washed in 300 mM NaCl, 30 mM sodium citrate, for 15 min,
rinsed twice in H2O, blocked for 10 min with 2% bovine
serum albumin in phosphate-buffered saline, treated with
streptavidin-alkaline phosphatase diluted 1:500 in 100 mM
Tris, 50 mM NaCl, pH 7.5, rinsed five times in
H2O, and developed using nitro blue tetrazolium chloride
and 5-bromo-4-chloro-3-indolyl phosphate as a substrate. The slides
were not counterstained.
DNA Fragmentation Analysis--
After incubation with A2E (50 µM; 0.5% Me2SO; 16 h; 5%
CO2; 37 °C; darkness), cells were scraped from the
plates, washed once in phosphate-buffered saline, and resuspended in 1 ml of 10 mM Tris (pH 8), 10 mM EDTA, and 10 mM NaCl. SDS was added to a final concentration of 0.5%,
and proteins were digested with proteinase K (0.2 mg/ml) at 37 °C
for 5 h. Fresh proteinase K was added (0.2 mg/ml), and incubation
was continued for 4 h at 50 °C. The mixture was extracted once
with phenol/chloroform/isoamylalcohol (25:24:1) and twice with
chloroform/isoamylalcohol (24:1). NaCl (final concentration 300 mM) and ethanol (2.5 volumes) were added, and DNA was
precipitated overnight at 20 °C. After centrifugation for 10 min
at 4000 × g (4 °C), DNA was washed once with 70%
ethanol and air-dried for 1 h at room temperature. 100 µl of 10 mM Tris, pH 8, 1 mM EDTA, were added, and DNA
was allowed to rehydrate for 2 days at 4 °C. RNA was digested by
incubation at 37 °C for 1 h with 20 µg of RNase A. DNA
concentration was determined by A260
reading. 15 µg of total DNA were analyzed by electrophoresis on a
1.5% agarose gel and stained with SybrGreen (Molecular Probes).
Isolation of Mitochondria and Cytochrome Oxidase--
Liver
mitochondria were obtained from overnight-starved rats weighing
200 g by differential centrifugation (36). COX was isolated from
rat liver as described (37).
Oxygen Consumption Measurements--
Oxygen consumption was
measured at 28 °C with a Clark-type oxygen electrode (YSI, Inc.,
Yellow Springs, OH) under continuous stirring. Mitochondria were
diluted to 1 mg of mitochondrial protein/ml in a buffer containing 300 mM sucrose, 5 mM HEPES, pH 7.4, 0.5 mM EGTA, and 0.5 mg of fatty acid-free bovine serum
albumin/ml. A2E was added to the mitochondrial suspension before
rotenone (5 µM) and succinate (0.4-1.2 mM).
The reaction time was normally 4 min or as indicated. Cytochrome
c (1 µM) or cardiolipin (1 µg/ml) was added
as indicated. COX (263 µg/ml) assays were performed in 40 mM phosphate buffer, pH 7.0, and 50 µM EDTA
with 1 mM ascorbate and 0.4 mM
tetramethyl-p-phenylenediamine.
 |
RESULTS |
A2E Induces Apoptosis in Retinal Pigment Epithelial
Cells--
A2E, a component of lipofuscin in the RPE (16, 38) affects
lysosomal function (39), inhibits growth of human RPE cells in
vitro (40, 41), and mediates blue light-induced apoptosis to RPE
cells (42). To investigate the molecular details of A2E toxicity, we
isolated and cultured pig RPE cells and exposed them to increasing
concentrations of A2E. Application of as little as 25 µM
A2E, which results in an intracellular content of A2E found in human
eyes (40), induces apoptosis in PRE cells within 24 h as evidenced
by the internucleosomal DNA fragmentation of genomic DNA (Fig.
1A) and positive TUNEL
staining (Fig. 1B). The latter was comparable with the
staining caused by staurosporine, a known apoptosis-inducing agent
(Fig. 1C), and was not detected in cells exposed to solvent
alone (Fig. 1D).

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 1.
A2E induces apoptosis in retinal pigment
epithelial cells. A, cultured retinal pigment
epithelium cells were exposed to 50 µM A2E in
0.5% Me2SO (lane 2) or to solvent alone
(lane 1). DNA was extracted after 24 h and
analyzed by agarose gel electrophoresis. M, 100-base pair
DNA ladder as marker. B-D, TUNEL staining of cells exposed
for 24 h to 25 µM A2E (B), 0.5 µM staurosporine (C), or 0.5%
Me2SO (DMSO) (D). Scale
bar, 100 µm.
|
|
A2E Accumulates in Mitochondria and Induces Release of Proapoptotic
Mitochondrial Proteins--
Mitochondria participate in the execution
of apoptosis induced by many agents, including lipophilic cations (29)
and can release proapoptotic proteins. This is often but not always
followed by activation of proteases known as caspases. Because we
suspected an involvement of mitochondria in cell death induced by the
lipophilic cation A2E, we also investigated cerebellar granule cells
(CGC), in which mitochondria abound. Significant apoptotic death was induced in these cells at A2E concentrations of >10 µM.
Interestingly, already lower A2E concentrations decreased mitochondrial
function as measured by the MTT assay (Fig.
2) or a decrease in TMRE fluorescence (not shown). The decline in mitochondrial activity precedes the death
of CGC (Fig. 2). These cells accumulate A2E in mitochondria as shown by
comparison of the localization of A2E with the mitochondrial marker
TMRE (Fig. 3A). We found that
after deenergization of mitochondria in CGC A2E is for presently
unknown reasons retained much longer than TMRE in the organelles (Fig.
3B), an observation confirmed with isolated rat liver
mitochondria.2 The cells
release in response to A2E the proapoptotic proteins cytochrome
c (Fig. 4, A-F)
and AIF (Fig. 4, G-M) from mitochondria into the cytoplasm
and nucleus. The two other cell types tested, the neuroblastoma lines
CHP-100 and SH-SY5Y, also underwent apoptosis when exposed to A2E in a
similar concentration range (data not shown). In none of the cell types
investigated was death induced by A2E apparently related to caspase
activation, since death was not preventable by 100 µM
benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone or other established
caspase inhibitors (data not shown). Similarly, A2E treatment did not
activate caspase-3 in cultured RPE cells (data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
A2E decreases mitochondrial activity and
causes loss of cell viability. CGC were incubated in medium
containing A2E concentrations as indicated. After 18 and 45 h, the
capacity of the cell population to reduce MTT (mitochondrial activity)
was determined (closed symbols). Data are
standardized to untreated control cells as 100% reference value. In
parallel cultures, cell viability was determined by staining with the
chromatin dyes H-33342 and SYTOX. The percentage of cells with intact
plasma membrane and noncondensed chromatin (open
symbols) was determined. Data represent means ± S.D.
of three independent experiments.
|
|

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 3.
A2E is localized in mitochondria. CGC
cultures were exposed to A2E (20 µM) for 6 h.
Solvent (A) or carbonylcyanide-3-chlorophenylhydrazone
(CCCP, 100 µM) (B) was added, and
live neurons were stained with TMRE and H-33342 and imaged by
multichannel confocal microscopy. A2E fluorescence is represented in
green, TMRE in red, and chromatin structure in
blue. Co-localization of A2E and TMRE appears as
yellow (artificial color fusions). Scale
bar, 50 µm.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4.
A2E triggers release of cytochrome
c and of apoptosis-inducing factor.
A-F, CGC cultures were exposed to 20 µM A2E
(D-F) or solvent (A-C) for 20 h, fixed,
stained for chromatin structure (H-33342, red;
A and D) and cytochrome c
(green; B and E), and imaged by
confocal microscopy. Optical sections were obtained at the level of the
neuronal somata, where mitochondria (B) lie in a close
circle around the nucleus. A2E leads to the appearance of cytochrome
c in the cytosol and the nucleus as evidenced by the fusion
image (yellow; F). G-M, CGC cultures
were exposed to 20 µM A2E (K-M) or solvent
control (G-I), fixed after 24 h, stained for chromatin
structure (H-33342, red; G and K) and
apoptosis-inducing factor (green; H and
L), and imaged simultaneously by confocal microscopy
(I and M). A2E leads to the appearance of AIF in
the cytosol and the nucleus as evidenced by the fusion image
(yellow; M). Scale bar, 25 µm.
|
|
A2E Inhibits Respiration of Isolated Mitochondria and Cytochrome
Oxidase--
A2E is a lipophilic cation, and energized mitochondria
avidly accumulate such ions via their membrane potential. To gain
insight into the mechanism by which A2E induces apoptosis, we
investigated the response of isolated mitochondria and COX to A2E. Fig.
5 shows that oxygen consumption by
mitochondria respiring on succinate is suppressed by A2E in a
dose-dependent manner (Fig. 5A), A2E being more
potent in the light than in the dark (Fig. 5, B and C). In contrast to A2E, iso-A2E inhibits
respiration only marginally (Fig. 5B), most of the observed
inhibition being attributable to the conversion by light of
iso-A2E to A2E. The A2E-induced inhibition is apparently due
to detachment of cytochrome c from mitochondria, because
inhibition can be overcome by added cytochrome c or
cardiolipin (Fig. 5, C and D). When cardiolipin
is added before A2E, the latter is slightly less effective than when
the order of addition is reversed (Fig. 5D, trace
a versus trace b). Although
the difference is not very pronounced, it was observed in every
experiment (n = 4). Succinate-ferricyanide
oxidoreductase activity, which reflects electron flow from succinate
via its dehydrogenase to cytochrome bc1, was not affected
by A2E, nor was the reduction of cytochrome c by the
artificial electron donor dithionite (data not shown).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
A2E inhibits mitochondrial respiration.
Oxygen consumption of mitochondria isolated from rat liver was measured
in the absence and presence of A2E in a Clarke-type electrode in the
dark (aluminum foil-wrapped) or under light (70-watt tungsten lamp,
40-cm distance). A, concentration dependence of A2E
inhibition in the dark. B, comparison of 10 µM
HPLC-purified A2E and iso-A2E (content 89.2 ± 1.4 or
59.2 ± 7.8%, respectively). C, reversal of A2E (15 µM) inhibition by cytochrome c (1 µM). D, reversal of A2E (15 µM)
inhibition by cardiolipin (1 µg/ml). The following additions were
made: rotenone (5 µM) (I); succinate (0.5 mM) (II); A2E (15 µM)
(III); cardiolipin (1 µg/ml) (IV). Note that
the order of addition of A2E and cardiolipin is reversed in
traces a and b; representative
recordings are shown. The columns in A-C represent mean
values ± S.D. of four independent experiments.
|
|
Cardiolipin facilitates the binding of cytochrome c to
COX-containing membranes (43). The above results strongly suggest that
A2E inhibits mitochondrial respiration because it prevents cytochrome
c binding to the inner mitochondrial membrane and thereby interrupts electron flow between cytochrome bc1
and COX. To substantiate this, we measured oxygen consumption of
isolated COX. This is possible when electrons are provided by ascorbate
and mediated to cytochrome c by the dye
tetramethyl-p-phenylenediamine. Fig. 6A shows that also in this
well defined system, comprising besides the electron donor/mediator
only two proteins and COX-bound cardiolipin, A2E inhibits oxygen
consumption dose-dependently. Again, inhibition is
counteracted by cardiolipin addition (Fig. 6B,
trace a versus trace
b). When cardiolipin is added before A2E in this system, A2E
is totally ineffective (Fig. 6, B, trace
c versus trace d). As with
mitochondria, iso-A2E inhibited COX only marginally (data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
A2E inhibits oxygen consumption by cytochrome
oxidase. Oxygen consumption of cytochrome oxidase isolated from
rat liver was measured in the absence and presence of A2E in a
Clarke-type electrode. A, the columns represent
mean values ± S.D. of four independent experiments. B,
reversal of A2E (3 µM) inhibition by cardiolipin (1 µg/ml). The following additions were made: ascorbate/TMPD
(I); COX (II); cytochrome c
(III); cardiolipin (IV). Representative
recordings are shown. For experimental details, see "Experimental
Procedures."
|
|
 |
DISCUSSION |
Loss of pigment epithelial cells in the retina may result in the
so-called geographic atrophy, which is by far the most frequent form of
AMD. To date, no cure or prevention of this disease, which affects a
large number of elderly people, is available. A better understanding of
the molecular details of AMD's pathogenesis promises to provide
rationales to successfully retard the onset of the disease or even
prevent it. Here we show by several complementary experimental
approaches that the cationic A2E accumulates in mitochondria, inhibits
mitochondrial function, detaches proapoptotic proteins from
mitochondria and may thereby induce apoptosis.
A2E and its isomer iso-A2E have been isolated from the eyes
of elderly humans (17, 44) and rats (see below), but it is presently
unclear where and how these molecules are formed. In vitro,
A2E and iso-A2E are readily synthesized by mixing
all-trans-retinal with ethanolamine at slightly acidic pH
(17). In vivo, when light strikes the visual pigment
rhodopsin, the chromophore all-trans-retinal is liberated
from the photoreceptor outer segment membranes, reduced, and
transported into the RPE. Additionally, packets of photoreceptor discs
are rhythmically shed and phagocytosed by RPE cells (12). The last
steps of A2E formation were suggested to occur in RPE phagolysosomes due to the requirement of oxidizing and acidic conditions (44) and shown to result from the reaction of
all-trans-retinal molecules with a phosphatidylethanolamine
molecule, followed by hydrolysis of the adduct (44). A2E was also
detected in lysosomes of cells exposed in culture to the free compound
or to A2E coupled to low density lipoprotein particles (40, 45). A2E
inhibits hydrolytic activities in lysosomes (14, 39) and mediates blue light-induced damage to RPE cells (42).
Energized mitochondria establish across their inner membrane an
electric potential, negative charge inside, which drives sufficiently lipophilic cations nonspecifically into the organelles (46). We
therefore suspected that the lipophilic cations A2E and
iso-A2E accumulate in mitochondria. Our confocal microscopic
study indeed revealed the predominant presence of A2E in CGC
mitochondria. The presence of A2E in lysosomes but not in mitochondria
reported by others (39, 40), and the mitochondrial localization found in our study may suggest that after damaging lysosomes A2E can be
released and subsequently taken up by mitochondria. Alternatively, A2E
may initially accumulate in and be retained by mitochondria, which when
damaged may be engulfed by lysosomes. In contrast to these presumably
physiological intracellular steps of A2E distribution pathogenetic
steps leading to cell death may be mainly due to overloading of
mitochondria with the lipophilic cation.
A2E and iso-A2E are detergent-like wedge-shaped molecules
with slightly different dimensions. Their biological properties have
not been studied in detail, and it also remained to be elucidated whether both isomers are relevant in the disease process. We find that
A2E dose-dependently induces apoptosis in mammalian RPE
cells, approximately 50% killing of the cultured cells being achieved with 25 µM A2E. How may this relate to the in
vivo situation? From one eye of elderly humans on average about
830 pmol were isolated (17). Assuming that in the eye A2E is present
exclusively in RPE cells and evenly distributed, a concentration of
about 15 µM A2E in such cells of elderly humans can be
calculated. The age-related increase in human eyes is corroborated by
an age-dependent accumulation of A2E in rat eyes. Thus, we
detected on average about 4 pmol of A2E in the eyes of rats weighing
200 g and 42 pmol of A2E in the eyes of rats weighing about
350 g.
Apoptosis induced by A2E is preceded by a decline of mitochondrial
activity and is accompanied by the appearance of cytochrome c and AIF in the cytosol and nucleus, respectively. The
detachment of cytochrome c from the inner mitochondrial
membrane has at least two important consequences for mitochondria.
First, they experience oxidative stress because the reduction of the
respiratory chain members upstream of the cytochrome c
binding sites results in enhanced superoxide formation (47); second,
when electron flow is interrupted, mitochondrial ATP synthesis is
impaired. Both events are highly relevant for apoptosis because
oxidative stress and decreased energy levels further weaken
mitochondria, cause leakiness of their inner membrane, and favor
release of proapoptotic proteins from mitochondria (21, 48). AIF, a
novel pro-apoptotic protein, is strictly confined to mitochondria, and
translocates to the nucleus upon induction of apoptosis by various
stimuli (25). AIF translocation is correlated with large scale DNA
fragmentation and is probably responsible for apoptosis morphology in
the absence of caspases (24, 25).
At the cellular level, release of cytochrome c often but not
always results in the activation of the caspase cascade. In cells with
a defect in ATP generation activation of caspases can be entirely
prevented despite high cytosolic cytochrome c concentrations (23, 30, 32). This may explain the lack of inhibition of A2E-induced
cell death by the pancaspase inhibitor
benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone. Thus, caspases may
play at most only a minor role in A2E-induced apoptosis. There are
in vitro precedents for apoptosis independent of caspase
activation in the retina (49) or tumor cells (50).
To gain additional insight into the mechanism(s) by which A2E might
induce apoptosis, we studied its action on isolated mitochondria and
COX. We find inhibition by A2E but not by iso-A2E of
mitochondrial succinate-supported oxygen consumption and relief of the
inhibition by added cytochrome c or cardiolipin, a unique
phospholipid almost exclusively located in the inner mitochondrial
membrane, where it supports oxidative phosphorylation (51-53). The
restoration of respiratory activity may be due to a direct interaction
of A2E and cardiolipin at the level of COX or to binding of the anionic cardiolipin to the cationic A2E in solution. As to the latter, we did
not detect by UV-visible spectroscopy complex formation between the two
compounds (data not shown). Electron flow from succinate dehydrogenase
to complex III of the respiratory chain, however, is not affected by
A2E, as shown by ferricyanide reduction measurements. These findings
indicate that in mitochondria A2E impairs specifically the interaction
between cytochrome c and COX, a result corroborated by the
data obtained with the isolated enzyme complex. iso-A2E
causes only minor inhibition of respiration by mitochondria or isolated
COX, most or all of it being attributable to the conversion of
iso-A2E to A2E. This further underlines the specificity of
A2E's action and argues against a simple detergent-like effect of the
amphiphilic compound.
So far, no efficient AMD therapy or prevention exists. Carotenoids and
antioxidants (54), limiting exposure to light, or targeting of the
precursors of A2E (44) may be useful. Our findings suggest several
other promising strategies. One is supplementation with cardiolipin to
facilitate retention of cytochrome c in mitochondria, because the mitochondrial cardiolipin content and function decrease in
humans progressively with age to about 60% of the value found in
children (55, 56). Another possible strategy is the prevention of A2E
formation by, for example, outcompeting ethanolamine with a secondary
amine or outcompeting retinal with another aldehyde. Since the level of
retinal is decreased by retinal dehydrogenase, stimulation of this
enzyme may also be useful to counteract AMD.
 |
ACKNOWLEDGEMENT |
We thank Dr. Paolo Gazzotti (Institute of
Biochemistry, Swiss Federal Institute of Technology, Zurich) for kindly
providing rat liver COX and Heike Naumann for expert technical assistance.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Institute of
Biochemistry, Swiss Federal Institute of Technology,
Universitätstr. 16, CH-8092 Zurich, Switzerland. Tel.:
41-1-6323021 or -6323136; Fax: 41-1-6321121; E-mail:
richter@bc.biol.ethz.ch.
Published, JBC Papers in Press, September 26, 2000, DOI 10.1074/jbc.M007049200
2
C. Richter, unpublished result.
 |
ABBREVIATIONS |
The abbreviations used are:
AMD, age-related macular degeneration;
AIF, apoptosis-inducing factor;
A2E, N-retinyl-N-retinylidene ethanolamine
(2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E,7E-octatetraenyl]-1-(2-hydroxyethyl)-4-[4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E-hexatrienyl]-pyridinium);
CGC, cerebellar granule cells;
COX, cytochrome oxidase;
RPE, retinal
pigment epithelium;
MTT, 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrasodium bromide;
TMRE, tetramethylrhodamine ethylester;
HPLC, high pressure liquid
chromatography;
TUNEL, terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling.
 |
REFERENCES |
| 1.
|
Klein, R.,
Klein, B. E.,
and Linton, K. L.
(1992)
Ophthalmology
99,
933-943
|
| 2.
|
Bressler, N. M.,
Bressler, S. B.,
and Fine, S. L.
(1988)
Surv. Ophthalmol.
32,
375-413
|
| 3.
|
Zarbin, M. A.
(1998)
Eur. J. Ophthalmol.
8,
199-206
|
| 4.
|
Allikmets, R.,
Shroyer, N. F.,
Singh, N.,
Seddon, J. M.,
Lewis, R. A.,
Bernstein, P. S.,
Peiffer, A.,
Zabriskie, N. A.,
Li, Y.,
Hutchinson, A.,
Dean, M.,
Lupski, J. R.,
and Leppert, M.
(1997)
Science
277,
1805-1807
|
| 5.
|
Allikmets, R.
(1999)
Eur. J. Ophthalmol.
9,
255-265
|
| 6.
|
Gorin, M. B.,
Breitner, J. C.,
De Jong, P. T.,
Hageman, G. S.,
Klaver, C. C.,
Kuehn, M. H.,
and Seddon, J. M.
(1999)
Mol. Vis.
5,
29
|
| 7.
|
Silvestri, G.
(1997)
Mol. Med. Today
3,
84-91
|
| 8.
|
Weng, J.,
Mata, N. L.,
Azarian, S. M.,
Tzekov, R. T.,
Birch, D. G.,
and Travis, G. H.
(1999)
Cell
98,
13-23
|
| 9.
|
Cruickshanks, K. J.,
Klein, R.,
and Klein, B. E.
(1993)
Arch. Ophthalmol.
111,
514-518
|
| 10.
|
Leibowitz, H. M.,
Krueger, D. E.,
Maunder, L. R.,
Milton, R. C.,
Kini, M. M.,
Kahn, H. A.,
Nickerson, R. J.,
Pool, J.,
Colton, T. L.,
Ganley, J. P.,
Loewenstein, J. I.,
and Dawber, T. R.
(1980)
Surv. Ophthalmol.
24 (suppl.),
335-610
|
| 11.
|
Young, R. W.,
and Bok, D.
(1969)
J. Cell Biol.
42,
392-403
|
| 12.
|
Young, R. W.
(1976)
Invest. Ophthalmol. Vis. Sci.
15,
700-725
|
| 13.
|
Feeney, L.
(1978)
Invest. Ophthalmol. Vis. Sci.
17,
583-600
|
| 14.
|
Eldred, G. E.
(1995)
Gerontology
41 (Suppl. 2),
15-28
|
| 15.
|
Ishibashi, T.,
Patterson, R.,
Ohnishi, Y.,
Inomata, H.,
and Ryan, S. J.
(1986)
Am. J. Ophthalmol.
101,
342-353
|
| 16.
|
Eldred, G. E.,
and Lasky, M. R.
(1993)
Nature
361,
724-726
|
| 17.
|
Parish, C. A.,
Hashimoto, M.,
Nakanishi, K.,
Dillon, J.,
and Sparrow, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14609-14613
|
| 18.
|
Xu, G. Z.,
Li, W. W.,
and Tso, M. O.
(1996)
Trans. Am. Ophthalmol. Soc.
94,
411-430
|
| 19.
|
Kerr, J. F.,
Wyllie, A. H.,
and Currie, A. R.
(1972)
Br. J. Cancer
26,
239-257
|
| 20.
|
Thompson, C. B.
(1995)
Science
267,
1456-1462
|
| 21.
|
Kroemer, G.,
and Reed, J. C.
(2000)
Nat. Med.
6,
513-519
|
| 22.
|
Wallace, D. C.
(1999)
Science
283,
1482-1488
|
| 23.
|
Leist, M.,
Single, B.,
Naumann, H.,
Fava, E.,
Simon, B.,
Kuhnle, S.,
and Nicotera, P.
(1999)
Exp. Cell Res.
249,
396-403
|
| 24.
|
Susin, S. A.,
Lorenzo, H. K.,
Zamzami, N.,
Marzo, I.,
Snow, B. E.,
Brothers, G. M.,
Mangion, J.,
Jacotot, E.,
Costantini, P.,
Loeffler, M.,
Larochette, N.,
Goodlett, D. R.,
Aebersold, R.,
Siderovski, D. P.,
Penninger, J. M.,
and Kroemer, G.
(1999)
Nature
397,
441-446
|
| 25.
|
Daugas, E.,
Susin, S. A.,
Zamzami, N.,
Ferri, K. F.,
Irinopoulou, T.,
Larochette, N.,
Prevost, M. C.,
Leber, B.,
Andrews, D.,
Penninger, J.,
and Kroemer, G.
(2000)
FASEB J.
14,
729-739
|
| 26.
|
Susin, S. A.,
Lorenzo, H. K.,
Zamzami, N.,
Marzo, I.,
Brenner, C.,
Larochette, N.,
Prevost, M. C.,
Alzari, P. M.,
and Kroemer, G.
(1999)
J. Exp. Med.
189,
381-394
|
| 27.
|
Esser, P.,
Grisanti, S.,
Kociok, N.,
Abts, H.,
Hueber, A.,
Unfried, K.,
Heimann, K.,
and Weller, M.
(1997)
Invest. Ophthalmol. Vis. Sci.
38,
2852-2856
|
| 28.
|
Schousboe, A.,
Meier, E.,
Dreijer, J.,
and Hertz, L.
(1989)
in
A Dissection and Tissue Culture Manual of the Nervous System
(Sahar, A.
, de Vellis, J.
, Vernadakis, A.
, and Haber, B., eds)
, pp. 203-206, A. R. Liss, New York
|
| 29.
|
Leist, M.,
Volbracht, C.,
Fava, E.,
and Nicotera, P.
(1998)
Mol. Pharmacol.
54,
789-801
|
| 30.
|
Volbracht, C.,
Leist, M.,
and Nicotera, P.
(1999)
Mol. Med.
5,
477-489
|
| 31.
|
Leist, M.,
Fava, E.,
Montecucco, C.,
and Nicotera, P.
(1997)
Eur. J. Neurosci.
9,
1488-1498
|
| 32.
|
Leist, M.,
Single, B.,
Castoldi, A. F.,
Kuhnle, S.,
and Nicotera, P.
(1997)
J. Exp. Med.
185,
1481-1486
|
| 33.
|
Single, B.,
Leist, M.,
and Nicotera, P.
(1998)
Cell Death Differ.
5,
1001-1003
|
| 34.
|
Latta, M.,
Kunstle, G.,
Leist, M.,
and Wendel, A.
(2000)
J. Exp. Med.
191,
1975-1986
|
| 35.
|
Eldred, G. E.,
and Katz, M. L.
(1988)
Exp. Eye Res.
47,
71-86
|
| 36.
|
Schlegel, J.,
Schweizer, M.,
and Richter, C.
(1992)
Biochem. J.
285,
65-69
|
| 37.
|
Aldez, I. Z.,
and Cascarano, J.
(1977)
J. Bioenerg. Biomembr.
9,
237-253
|
| 38.
|
Reinboth, J. J.,
Gautschi, K.,
Munz, K.,
Eldred, G. E.,
and Reme, C. E.
(1997)
Exp. Eye Res.
65,
639-643
|
| 39.
|
Holz, F. G.,
Schutt, F.,
Kopitz, J.,
Eldred, G. E.,
Kruse, F. E.,
Volcker, H. E.,
and Cantz, M.
(1999)
Invest. Ophthalmol. Vis. Sci.
40,
737-743
|
| 40.
|
Sparrow, J. R.,
Parish, C. A.,
Hashimoto, M.,
and Nakanishi, K.
(1999)
Invest. Ophthalmol. Vis. Sci.
40,
2988-2995
|
| 41.
|
Cubeddu, R.,
Taroni, P.,
Hu, D. N.,
Sakai, N.,
Nakanishi, K.,
and Roberts, J. E.
(1999)
Photochem. Photobiol.
70,
172-175
|
| 42.
|
Sparrow, J. R.,
Nakanishi, K.,
and Parish, C. A.
(2000)
Invest. Ophthalmol. Vis. Sci.
41,
1981-1989
|
| 43.
|
Salamon, Z.,
and Tollin, G.
(1996)
Biophys. J.
71,
858-867
|
| 44.
|
Mata, N. L.,
Weng, J.,
and Travis, G. H.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
7154-7159
|
| 45.
|
Holz, F. G.,
Schutt, F.,
Kopitz, J.,
and Volcker, H. E.
(1999)
Ophthalmologe
96,
781-785
|
| 46.
|
Chen, L. B.
(1988)
Annu. Rev. Cell Biol.
4,
155-181
|
| 47.
|
Cai, J.,
and Jones, D. P.
(1998)
J. Biol. Chem.
273,
11401-11404
|
| 48.
|
Richter, C.,
Schweizer, M.,
Cossarizza, A.,
and Franceschi, C.
(1996)
FEBS Lett.
378,
107-110
|
| 49.
|
Carmody, R. J.,
and Cotter, T. G.
(2000)
Cell Death Differ.
7,
282-291
|
| 50.
|
Nylandsted, J.,
Rohde, M.,
Brand, K.,
Bastholm, L.,
Elling, F.,
and Jäättela, M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
7871-7876
|
| 51.
|
Koshkin, V.,
and Greenberg, M. L.
(2000)
Biochem. J.
347,
687-691
|
| 52.
|
Hoch, F. L.
(1992)
Biochim. Biophys. Acta
1113,
71-133
|
| 53.
|
Hoch, F. L.
(1998)
J. Bioenerg. Biomembr.
30,
511-532
|
| 54.
|
Snodderly, D. M.
(1995)
Am. J. Clin. Nutr.
62 (suppl.),
1448-1461
|
| 55.
|
Ames, B. N.,
Shigenaga, M. K.,
and Hagen, T. M.
(1995)
Biochim. Biophys. Acta
1271,
165-170
|
| 56.
|
Maftah, A.,
Ratinaud, M. H.,
Dumas, M.,
Bonte, F.,
Meybeck, A.,
and Julien, R.
(1994)
Mech. Ageing Dev.
77,
83-96
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Vives-Bauza, M. Anand, A. K. Shirazi, J. Magrane, J. Gao, H. R. Vollmer-Snarr, G. Manfredi, and S. C. Finnemann
The Age Lipid A2E and Mitochondrial Dysfunction Synergistically Impair Phagocytosis by Retinal Pigment Epithelial Cells
J. Biol. Chem.,
September 5, 2008;
283(36):
24770 - 24780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Radu, Q. Yuan, J. Hu, J. H. Peng, M. Lloyd, S. Nusinowitz, D. Bok, and G. H. Travis
Accelerated Accumulation of Lipofuscin Pigments in the RPE of a Mouse Model for ABCA4-Mediated Retinal Dystrophies following Vitamin A Supplementation
Invest. Ophthalmol. Vis. Sci.,
September 1, 2008;
49(9):
3821 - 3829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schmitz-Valckenberg, L. Guo, A. Maass, W. Cheung, A. Vugler, S. E. Moss, P. M. G. Munro, F. W. Fitzke, and M. F. Cordeiro
Real-Time In Vivo Imaging of Retinal Cell Apoptosis after Laser Exposure
Invest. Ophthalmol. Vis. Sci.,
June 1, 2008;
49(6):
2773 - 2780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iriyama, R. Fujiki, Y. Inoue, H. Takahashi, Y. Tamaki, S. Takezawa, K. Takeyama, W.-D. Jang, S. Kato, and Y. Yanagi
A2E, a Pigment of the Lipofuscin of Retinal Pigment Epithelial Cells, Is an Endogenous Ligand for Retinoic Acid Receptor
J. Biol. Chem.,
May 2, 2008;
283(18):
11947 - 11953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Golczak, A. Maeda, G. Bereta, T. Maeda, P. D. Kiser, S. Hunzelmann, J. von Lintig, W. S. Blaner, and K. Palczewski
Metabolic Basis of Visual Cycle Inhibition by Retinoid and Nonretinoid Compounds in the Vertebrate Retina
J. Biol. Chem.,
April 11, 2008;
283(15):
9543 - 9554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T.V.M. de Jong
Age-Related Macular Degeneration
N. Engl. J. Med.,
October 5, 2006;
355(14):
1474 - 1485.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D M Paskowitz, M M LaVail, and J L Duncan
Light and inherited retinal degeneration
Br. J. Ophthalmol.,
August 1, 2006;
90(8):
1060 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Whitehead, J. A. Mares, and R. P. Danis
Macular Pigment: A Review of Current Knowledge
Arch Ophthalmol,
July 1, 2006;
124(7):
1038 - 1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Owsley, G. McGwin, G. R. Jackson, D. C. Heimburger, C. J. Piyathilake, R. Klein, M. F. White, and K. Kallies
Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy.
Invest. Ophthalmol. Vis. Sci.,
April 1, 2006;
47(4):
1310 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kasahara, L.-R. Lin, Y.-S. Ho, and V. N. Reddy
SOD2 Protects against Oxidation-Induced Apoptosis in Mouse Retinal Pigment Epithelium: Implications for Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci.,
September 1, 2005;
46(9):
3426 - 3434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Reme
The Dark Side of Light: Rhodopsin and the Silent Death of Vision The Proctor Lecture
Invest. Ophthalmol. Vis. Sci.,
August 1, 2005;
46(8):
2672 - 2682.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Brogan, T. J. Dickerson, G. E. Boldt, and K. D. Janda
Altered retinoid homeostasis catalyzed by a nicotine metabolite: Implications in macular degeneration and normal development
PNAS,
July 26, 2005;
102(30):
10433 - 10438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Strauss
The Retinal Pigment Epithelium in Visual Function
Physiol Rev,
July 1, 2005;
85(3):
845 - 881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. E. Fishkin, J. R. Sparrow, R. Allikmets, and K. Nakanishi
Isolation and characterization of a retinal pigment epithelial cell fluorophore: An all-trans-retinal dimer conjugate
PNAS,
May 17, 2005;
102(20):
7091 - 7096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Kim, N. Fishkin, J. Kong, K. Nakanishi, R. Allikmets, and J. R. Sparrow
Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E
PNAS,
August 10, 2004;
101(32):
11668 - 11672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Radu, N. L. Mata, A. Bagla, and G. H. Travis
Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration
PNAS,
April 20, 2004;
101(16):
5928 - 5933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rozanowska, A. Pawlak, B. Rozanowski, C. Skumatz, M. Zareba, M. E. Boulton, J. M. Burke, T. Sarna, and J. D. Simon
Age-Related Changes in the Photoreactivity of Retinal Lipofuscin Granules: Role of Chloroform-Insoluble Components
Invest. Ophthalmol. Vis. Sci.,
April 1, 2004;
45(4):
1052 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M A Mainster and J R Sparrow
How much blue light should an IOL transmit?
Br. J. Ophthalmol.,
December 1, 2003;
87(12):
1523 - 1529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zhang, J. Baffi, S. W. Cousins, and K. G. Csaky
Oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor
J. Cell Sci.,
May 15, 2003;
116(10):
1915 - 1923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Sparrow, H. R. Vollmer-Snarr, J. Zhou, Y. P. Jang, S. Jockusch, Y. Itagaki, and K. Nakanishi
A2E-epoxides Damage DNA in Retinal Pigment Epithelial Cells. VITAMIN E AND OTHER ANTIOXIDANTS INHIBIT A2E-EPOXIDE FORMATION
J. Biol. Chem.,
May 9, 2003;
278(20):
18207 - 18213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Sparrow
Therapy for macular degeneration: Insights from acne
PNAS,
April 15, 2003;
100(8):
4353 - 4354.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Radu, N. L. Mata, S. Nusinowitz, X. Liu, P. A. Sieving, and G. H. Travis
From the Cover: Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration
PNAS,
April 15, 2003;
100(8):
4742 - 4747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Haralampus-Grynaviski, L. E. Lamb, C. M. R. Clancy, C. Skumatz, J. M. Burke, T. Sarna, and J. D. Simon
Spectroscopic and morphological studies of human retinal lipofuscin granules
PNAS,
March 18, 2003;
100(6):
3179 - 3184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dayhaw-Barker
Retinal Pigment Epithelium Melanin and Ocular Toxicity
International Journal of Toxicology,
November 1, 2002;
21(6):
451 - 454.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Alge, S. G. Priglinger, A. S. Neubauer, A. Kampik, M. Zillig, H. Bloemendal, and U. Welge-Lussen
Retinal Pigment Epithelium Is Protected Against Apoptosis by {alpha}B-Crystallin
Invest. Ophthalmol. Vis. Sci.,
November 1, 2002;
43(11):
3575 - 3582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jiang, S. E. Moriarty, H. Grossniklaus, K. C. Nelson, D. P. Jones, and P. Sternberg Jr
Increased Oxidant-Induced Apoptosis in Cultured Nondividing Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
August 1, 2002;
43(8):
2546 - 2553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. De and T. P. Sakmar
Interaction of A2E with Model Membranes. Implications to the Pathogenesis of Age-related Macular Degeneration
J. Gen. Physiol.,
July 30, 2002;
120(2):
147 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Finnemann, L. W. Leung, and E. Rodriguez-Boulan
The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium
PNAS,
March 19, 2002;
99(6):
3842 - 3847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gao, A. Wenzel, C. Grimm, S. R. Vavricka, D. Benke, P. J. Meier, and C. E. Reme
Localization of Organic Anion Transport Protein 2 in the Apical Region of Rat Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci.,
February 1, 2002;
43(2):
510 - 514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Stone, V. C. Sheffield, and G. S. Hageman
Molecular genetics of age-related macular degeneration
Hum. Mol. Genet.,
October 1, 2001;
10(20):
2285 - 2292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hoppe, A. D. Marmorstein, E. A. Pennock, and H. F. Hoff
Oxidized Low Density Lipoprotein-Induced Inhibition of Processing of Photoreceptor Outer Segments by RPE
Invest. Ophthalmol. Vis. Sci.,
October 1, 2001;
42(11):
2714 - 2720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Delori, D. G. Goger, and C. K. Dorey
Age-Related Accumulation and Spatial Distribution of Lipofuscin in RPE of Normal Subjects
Invest. Ophthalmol. Vis. Sci.,
July 1, 2001;
42(8):
1855 - 1866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yang, R. Gross, S. Basinger, and S. Wu
Apoptotic cell death of cultured salamander photoreceptors induced by cccp: CsA-insensitive mitochondrial permeability transition
J. Cell Sci.,
January 5, 2001;
114(9):
1655 - 1664.
[Abstract]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|